First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Prolonged immigration detention is significantly associated with worsened self-rated health, along with high rates of ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

Michael Ashley Stein, PhD, JD, speaks about how disabled individuals are at a disadvantage when it comes to preparing for ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy at Minnesota Oncology, discusses how the prospect of patient ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...